Weave Communications Inc Dossier
|
SectorInformation Technology IndustryApplication Software Beta (adjusted)1.44 Intrinsic Value $9.95median of 3 methodsbased on filings through 30 Jun 2026 Market Price $7.38Price as of 30 Sep 2026 UndervaluedIntrinsic value is 35% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $593.7M Enterprise Value $546.1M Shares Outstanding 80.6M diluted Moat Rating None Next Earnings Date5 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Weave Communications is successfully transitioning from a pure-play SMB communications tool into an AI-powered patient engagement and payment platform. The company's Q1 2026 results demonstrate accelerating revenue growth (17.4% YoY) and significant operating leverage, with non-GAAP operating income reaching $2.5 million. Backed by a constructive cooperation agreement with activist investors Engine Capital and 2717 Partners, the newly formed Finance Committee is poised to optimize capital allocation and drive long-term shareholder value. Trading at a reasonable enterprise value-to-revenue multiple, Weave represents an attractive vertical SaaS play with a strong data moat and expanding margins. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$8.00 Mean target$8.75 High · most bullish analyst$9.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario A worsening SMB macroeconomic environment causes healthcare practices to cut software spend, leading to elevated churn. Competitors, including practice management system (PMS) vendors, bundle basic communication and AI tools at little to no incremental cost, eroding Weave's market share and forcing price concessions that compress margins. Base CaseCentral scenario Weave continues to execute on its AI roadmap, specifically upselling its TrueLark-powered AI receptionist (priced at an incremental $250/month) to its base of nearly 40,000 locations. The exclusive partnership with the American Dental Association (ADA) provides a steady pipeline of low-cost customer acquisitions. Operating margins continue to expand as payment processing volumes scale, allowing the company to meet or exceed its full-year 2026 revenue guidance of $275M to $278M and non-GAAP operating income of $8M to $12M. Bull CaseUpside scenario Weave's bull case centers on its ability to compound customer locations and ARPU by transitioning to a hybrid, usage-based AI pricing model (such as its TrueLark integration) that addresses clinic labor shortages and drives higher product attachment. This shift, combined with strong momentum in Weave Payments and expansion into specialty medical markets, is expected to accelerate operating leverage, expand non-GAAP gross margins (which reached 73.2% in Q1 2026), and support a gradual valuation re-rating. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |